Arimidex®: A potent and selective fourth-generation aromatase inhibitor
- 1 January 1994
- journal article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 30 (1), 103-111
- https://doi.org/10.1007/bf00682745
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer.Journal of Clinical Oncology, 1992
- Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.1989
- Inhibition of Aromatase With CGS 16949A in Postmenopausal Women*Journal of Clinical Endocrinology & Metabolism, 1989
- Aminoglutethimide as Treatment of Postmenopausal Women with Advanced Breast CarcinomaAnnals of Internal Medicine, 1982
- Aminoglutethimide: Review of Pharmacology and Clinical UsePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1981
- A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast CancerThe New England Journal of Medicine, 1981